MED-EL USA announces FDA approval of SONNET 3 audio processor with built-in direct streaming, compact design and enhanced features.

PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, announced today the appointment of ...

Reports Q1 revenue $, consensus $. “We have made strides in our Phase 1 SB101 trial with established clinical benefit including a 45% reduction ...

Sonnet BioTherapeutics (SONN) announced the appointment of Stephen McAndrew, Ph.D., as Chief Business Officer, effective February 17, 2025.

The upgraded Claude 3.5 Sonnet, the latest and most intelligent model in the Claude model family from artificial intelligence ...

Sonar is built on top of Meta’s open-source Llama 3.3 70B. It is powered by Cerebras Inference, which claims to be the ...

One in five (20%) believe classic love poetry only focuses on hetero-romantic love, while 60% claim the lack of representation frustrates them ...

The company claims its newly upgraded model is number one in user satisfaction and speed - but its methodology is unclear.

Closely aligned to the theme of romantic love is that of desire, and across the centuries poets have written about the ...

Forage Floral is not your typical florist shop. It's more of a studio. She has pre-planned arrangements customers can choose ...

South African stage legend John Kani has become known for films such as “Black Panther,” and now stars in his play “Kunene ...

PRINCETON - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company specializing in immunotherapy treatments with a current market capitalization of $4.69 million, ...